Cardiff Oncology, Inc. Quarterly Current Ratio in % from Q3 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Cardiff Oncology, Inc. quarterly Current Ratio history and growth rate from Q3 2012 to Q3 2024.
  • Cardiff Oncology, Inc. Current Ratio for the quarter ending September 30, 2024 was 568 %, a 50.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 568 -575 -50.3% Sep 30, 2024
Q2 2024 670 -607 -47.5% Jun 30, 2024
Q1 2024 802 -607 -43.1% Mar 31, 2024
Q4 2023 969 -616 -38.9% Dec 31, 2023
Q3 2023 1.14K -624 -35.3% Sep 30, 2023
Q2 2023 1.28K -769 -37.6% Jun 30, 2023
Q1 2023 1.41K -1.05K -42.8% Mar 31, 2023
Q4 2022 1.58K -1.1K -41.1% Dec 31, 2022
Q3 2022 1.77K -917 -34.2% Sep 30, 2022
Q2 2022 2.05K -103 -4.79% Jun 30, 2022
Q1 2022 2.46K +896 +57.2% Mar 31, 2022
Q4 2021 2.69K +1.7K +173% Dec 31, 2021
Q3 2021 2.68K +2.24K +507% Sep 30, 2021
Q2 2021 2.15K +1.83K +568% Jun 30, 2021
Q1 2021 1.57K +1.32K +532% Mar 31, 2021
Q4 2020 984 +699 +245% Dec 31, 2020
Q3 2020 442 +108 +32.6% Sep 30, 2020
Q2 2020 322 -99.9 -23.7% Jun 30, 2020
Q1 2020 248 -255 -50.7% Mar 31, 2020
Q4 2019 286 -159 -35.8% Dec 31, 2019
Q3 2019 333 -54 -13.9% Sep 30, 2019
Q2 2019 421 +139 +49.1% Jun 30, 2019
Q1 2019 503 +333 +196% Mar 31, 2019
Q4 2018 445 +223 +101% Dec 31, 2018
Q3 2018 387 +94.1 +32.1% Sep 30, 2018
Q2 2018 283 -124 -30.6% Jun 30, 2018
Q1 2018 170 -322 -65.5% Mar 31, 2018
Q4 2017 222 -342 -60.7% Dec 31, 2017
Q3 2017 293 -347 -54.2% Sep 30, 2017
Q2 2017 407 -300 -42.4% Jun 30, 2017
Q1 2017 492 -321 -39.5% Mar 31, 2017
Q4 2016 564 -339 -37.6% Dec 31, 2016
Q3 2016 640 -230 -26.5% Sep 30, 2016
Q2 2016 707 -109 -13.3% Jun 30, 2016
Q1 2016 813 -118 -12.7% Mar 31, 2016
Q4 2015 903 -109 -10.8% Dec 31, 2015
Q3 2015 870 -398 -31.4% Sep 30, 2015
Q2 2015 815 -707 -46.4% Jun 30, 2015
Q1 2015 932 -319 -25.5% Mar 31, 2015
Q4 2014 1.01K -186 -15.5% Dec 31, 2014
Q3 2014 1.27K +64.6 +5.37% Sep 30, 2014
Q2 2014 1.52K +628 +70.1% Jun 30, 2014
Q1 2014 1.25K +281 +28.9% Mar 31, 2014
Q4 2013 1.2K +511 +74.6% Dec 31, 2013
Q3 2013 1.2K +820 +214% Sep 30, 2013
Q2 2013 895 Jun 30, 2013
Q1 2013 970 Mar 31, 2013
Q4 2012 686 Dec 31, 2012
Q3 2012 383 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.